AHCO vs. OPCH, AMED, BTSG, ADUS, AVAH, EHAB, LHCG, CHE, BBIO, and CYTK
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include Option Care Health (OPCH), Amedisys (AMED), BrightSpring Health Services (BTSG), Addus HomeCare (ADUS), Aveanna Healthcare (AVAH), Enhabit (EHAB), LHC Group (LHCG), Chemed (CHE), BridgeBio Pharma (BBIO), and Cytokinetics (CYTK). These companies are all part of the "medical" sector.
Option Care Health (NASDAQ:OPCH) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, community ranking, profitability and dividends.
In the previous week, AdaptHealth had 5 more articles in the media than Option Care Health. MarketBeat recorded 11 mentions for AdaptHealth and 6 mentions for Option Care Health. AdaptHealth's average media sentiment score of 0.95 beat Option Care Health's score of 0.33 indicating that Option Care Health is being referred to more favorably in the media.
Option Care Health has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.
Option Care Health currently has a consensus target price of $40.00, suggesting a potential upside of 34.14%. AdaptHealth has a consensus target price of $12.42, suggesting a potential upside of 30.98%. Given AdaptHealth's stronger consensus rating and higher possible upside, equities analysts clearly believe Option Care Health is more favorable than AdaptHealth.
AdaptHealth received 31 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 59.23% of users gave AdaptHealth an outperform vote while only 58.97% of users gave Option Care Health an outperform vote.
Option Care Health has higher revenue and earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.
Option Care Health has a net margin of 6.15% compared to Option Care Health's net margin of -21.45%. AdaptHealth's return on equity of 18.92% beat Option Care Health's return on equity.
98.1% of Option Care Health shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by insiders. Comparatively, 4.4% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Option Care Health beats AdaptHealth on 13 of the 17 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
